Mutual funds holding Glenmark Pharmaceuticals shares
116 mutual fund schemes held Glenmark Pharmaceuticals shares in their latest portfolios (October 2026, or September 2026 where a fund house's October 2026 portfolio is not yet in), worth about ₹8,124 cr in all. The largest holders by value are HDFC Mid Cap Fund (3.1% of the fund), Invesco India Mid Cap Fund (2.7% of the fund), Invesco India Contra Fund (2.0% of the fund).
Against the month before, 1 scheme added Glenmark Pharmaceuticals as a new holding and 1 sold out of it completely.
New holders: HDFC MNC Fund
Sold out: quant Consumption Fund
By category: Index Fund (56), Sectoral/Thematic (21), Large & Mid Cap (8), Arbitrage (8), Mid Cap (4), Multi Cap (4).
9 actively managed schemes holding it are rated A+ or A on their track record, among them Invesco India Mid Cap Fund, Invesco India Contra Fund, Quant ELSS Tax Saver Fund, Invesco India Large & Mid Cap Fund, HDFC Balanced Advantage Fund.
Every scheme holding Glenmark Pharmaceuticals, by value
| Scheme | Rating | % of fund | Value | Change |
|---|---|---|---|---|
| HDFC Mid Cap FundMid Cap | C | 3.06% | ₹3,081 cr | -0.01 |
| Invesco India Mid Cap FundMid Cap | A+ | 2.66% | ₹421 cr | -0.10 |
| Invesco India Contra FundValue / Contra | A+ | 2.03% | ₹390 cr | -0.03 |
| Quant ELSS Tax Saver FundELSS | A | 2.73% | ₹351 cr | +2.08 |
| Invesco India Large & Mid Cap FundLarge & Mid Cap | A+ | 2.17% | ₹270 cr | -0.40 |
| Quant Flexi Cap FundFlexi Cap | B | 3.46% | ₹249 cr | +0.02 |
| Quant Multi Cap FundMulti Cap | C | 3.41% | ₹248 cr | +0.99 |
| HDFC Large & Mid Cap FundLarge & Mid Cap | C | 0.86% | ₹242 cr | +0.00 |
| SBI Arbitrage FundArbitrage | A+ | 0.46% | ₹212 cr | – |
| HDFC Balanced Advantage FundBalanced Advantage | A | 0.20% | ₹203 cr | – |
| Mirae Asset Healthcare FundSectoral/Thematic | B | 4.61% | ₹164 cr | -0.17 |
| Nippon India Arbitrage FundArbitrage | B | 0.78% | ₹141 cr | – |
| Tata Mid Cap FundMid Cap | B | 2.39% | ₹137 cr | – |
| Quant Large & Mid Cap FundLarge & Mid Cap | B | 3.94% | ₹133 cr | -0.04 |
| UTI Nifty 200 Momentum 30 Index FundIndex Fund | A | 1.75% | ₹133 cr | – |
| HDFC Manufacturing FundSectoral/Thematic | – | 1.36% | ₹132 cr | +0.05 |
| Mahindra Manulife Mid Cap FundMid Cap | B | 2.65% | ₹130 cr | – |
| UTI Value FundValue / Contra | B | 1.09% | ₹98 cr | – |
| Axis Multicap FundMulti Cap | A+ | 0.75% | ₹92 cr | – |
| HDFC Arbitrage FundArbitrage | A | 0.32% | ₹83 cr | – |
| Axis Large & Mid Cap FundLarge & Mid Cap | B | 0.46% | ₹75 cr | – |
| HDFC Pharma and Healthcare FundSectoral/Thematic | A+ | 1.96% | ₹72 cr | -0.13 |
| Mahindra Manulife Multi Cap FundMulti Cap | B | 0.96% | ₹70 cr | – |
| Mahindra Manulife Small Cap FundSmall Cap | A+ | 1.28% | ₹66 cr | – |
| Mahindra Manulife Large & Mid Cap FundLarge & Mid Cap | B | 2.24% | ₹61 cr | – |
| Aditya Birla Sun Life Quant FundSectoral/Thematic | – | 3.03% | ₹56 cr | – |
| DSP Arbitrage fundArbitrage | B | 0.69% | ₹48 cr | – |
| quant Healthcare FundSectoral/Thematic | B | 9.38% | ₹39 cr | +0.04 |
| Edelweiss Nifty Midcap150 Momentum 50 Index FundIndex Fund | B | 2.15% | ₹36 cr | – |
| UTI Large & Mid Cap FundLarge & Mid Cap | B | 0.57% | ₹35 cr | – |
| Motilal Oswal Nifty Midcap 150 Index FundIndex Fund | B | 0.89% | ₹35 cr | +0.02 |
| Bank Of India Aggressive Hybrid FundAggressive Hybrid | A | 1.54% | ₹34 cr | – |
| Baroda BNP Paribas Arbitrage FundArbitrage | C | 3.15% | ₹32 cr | – |
| UTI - Healthcare FundSectoral/Thematic | B | 2.12% | ₹30 cr | – |
| Edelweiss Business Cycle FundSectoral/Thematic | – | 2.17% | ₹28 cr | – |
| Axis India Manufacturing FundSectoral/Thematic | – | 0.50% | ₹27 cr | – |
| Tata Nifty Midcap 150 Momentum 50 Index FundIndex Fund | B | 2.15% | ₹26 cr | – |
| Nippon India Nifty Midcap 150 Index FundIndex Fund | B | 0.89% | ₹23 cr | +0.02 |
| Invesco India Pharma and Healthcare FundSectoral/Thematic | – | 4.48% | ₹21 cr | -0.38 |
| Nippon India Nifty 500 Momentum 50 Index FundIndex Fund | A | 1.67% | ₹21 cr | +0.02 |
And 76 more schemes with smaller holdings.
Value: the scheme's assets under management × the stock's weight, approximate. Change: the weight against the previous month's portfolio, in percentage points; it moves with the share price as well as with buying and selling. Links go to each scheme's Regular plan.
Common questions
How many mutual funds hold Glenmark Pharmaceuticals shares?
116 schemes held Glenmark Pharmaceuticals in their latest monthly portfolios (October 2026, or September 2026 where a fund house's October 2026 portfolio is not yet in), worth about ₹8,124 cr in all.
Which mutual fund holds the most Glenmark Pharmaceuticals shares?
By value, HDFC Mid Cap Fund: about ₹3,081 cr, 3.06% of the fund.
Where does this data come from?
From the monthly portfolios that every fund house must publish by the 10th of the following month. Values are approximate: the fund's assets under management multiplied by the stock's weight in the portfolio.
This page lists which funds hold a stock. It is not a view on the stock or a recommendation to buy or sell it or any fund. Ratings describe past track records, not a forecast.
Send us your CAS and get a written report: which of your funds to keep, which to exit and when, where new SIPs should go, and what each change costs in tax.